Invention Grant
- Patent Title: Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof
- Patent Title (中): 用于治疗癌症和纤维化疾病的药物及其组合物和用途
-
Application No.: US13123424Application Date: 2009-09-21
-
Publication No.: US08637467B2Publication Date: 2014-01-28
- Inventor: Lan Huang , Hua Zhou , Shengtao Yuan
- Applicant: Lan Huang , Hua Zhou , Shengtao Yuan
- Applicant Address: CN Wuxi
- Assignee: Wuxi MTLH Biotechnology Co., Ltd.
- Current Assignee: Wuxi MTLH Biotechnology Co., Ltd.
- Current Assignee Address: CN Wuxi
- Agency: Fulbright & Jaworski LLP
- Priority: CN200810200937 20081009
- International Application: PCT/CN2009/074048 WO 20090921
- International Announcement: WO2010/040305 WO 20100415
- Main IPC: A61K38/16
- IPC: A61K38/16 ; C07K14/00

Abstract:
Provided is the composition of a peptide and its mutagenic version, or other derivatives with the same 3-D structure with activity to bind the extracellular domain of PDGFR-α, or -β, but does not dimerize by itself, wherein said peptide comprises the sequence shown as SEQ ID NO: 1, 2 or 3. Also provided is the composition of the nucleotide sequence encoding said peptide and its derivatives, and the usage of said peptide and derivatives of the peptide in preparation of medicine for the prevention and treatment of fibrosis diseases, such as liver, kidney, and lung fibrosis, primary cancer, and cancer metastasis, especially stomach cancer, liver cancer, breast cancer, and lung cancer.
Public/Granted literature
- US20110263513A1 Pharmaceutical Being Used For Treating Cancer and Fibrosis Disease and the Composition and Uses Thereof Public/Granted day:2011-10-27
Information query
IPC分类: